Sign In
Buy CSII
$20.00
+0 (+0%)
At Close: Jul 26, 2023
Cardiovascular Systems shares jump after deal to be bought by Abbott for $890 million
05:44am, Thursday, 09'th Feb 2023
Cardiovascular Systems CSII, -1.99% shares rose 47% to $19.58 in early premarket trade after Abbott ABT, -1.60% agreed to buy the company for $890 million, or $20 per share. CSI is a leader in devices
Cardiovascular Systems (CSII) Reports Q2 Loss, Misses Revenue Estimates
09:04pm, Wednesday, 08'th Feb 2023
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -33.33% and 2.70%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays
09:47am, Thursday, 19'th Jan 2023
Cardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada.
Cardiovascular Systems (CSII) Q1 Earnings Miss, Revenues Top
12:02pm, Friday, 11'th Nov 2022
The launch of the Scoreflex scoring balloon receives a positive response and generates over $1.7 million in sales during the first quarter for Cardiovascular Systems (CSII).
Cardiovascular Systems, Inc. (CSII) Q1 2023 Earnings Call Transcript
01:58pm, Saturday, 05'th Nov 2022
Cardiovascular Systems, Inc. (NASDAQ:CSII ) Q1 2023 Results Conference Call November 3, 2022 9:00 AM ET Company Participants Jack Nielsen - Vice President of Investor Relations Scott Ward - Chairman,
Cardiovascular Systems (CSII) Reports Q1 Loss, Tops Revenue Estimates
09:47am, Thursday, 03'rd Nov 2022
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -12.50% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
07:00am, Wednesday, 12'th Oct 2022
ST. PAUL, Minn.
Why Is Cardiovascular Systems (CSII) Down 18.9% Since Last Earnings Report?
01:09pm, Thursday, 01'st Sep 2022
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock?
A Debt-Free and Fairly Valued Medical Devices Company
02:42pm, Wednesday, 20'th Jul 2022
LeMaitre Vascular Inc. ( LMAT , Financial) has been on a roll—it has generated robust financial results and metrics that produced a high GF Score. But the share price has been in a slump.
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
07:00am, Wednesday, 13'th Jul 2022
ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
Cardiovascular Systems, Inc. (CSII) CEO Scott Ward on Q3 2022 Results - Earnings Call Transcript
07:42am, Sunday, 08'th May 2022
Cardiovascular Systems, Inc. (NASDAQ:CSII ) Q3 2022 Earnings Conference Call May 5, 2022 9:00 AM ET Company Participants Jack Nielsen - Vice President, Investor Relations Scott Ward - Chairman, Presid
Cardiovascular Systems' (CSII) Q3 Earnings Top Estimates
11:22am, Thursday, 05'th May 2022
Cardiovascular Systems' (CSII) third-quarter revenues declined year over year due to lower Coronary and peripheral revenues.
Cardiovascular Systems (CSII) Reports Q3 Loss, Lags Revenue Estimates
09:47am, Wednesday, 04'th May 2022
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of 10.71% and 2%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Medical Product Stocks Poised to Beat This Earnings Season
09:02am, Monday, 25'th Apr 2022
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
Here's Why You Should Hold on to Cardiovascular Systems (CSII)
11:17am, Wednesday, 13'th Apr 2022
Investors are optimistic about Cardiovascular Systems' (CSII) robust international growth and upcoming launches.
